Biohaven Pharmaceutical Holding Company Ltd BHVN:NYSE

RT Quote | Last NYSE, VOL From CTA | USD
Last | 10:50 AM EDT
147.91quote price arrow down-0.09 (-0.06%)
Volume
36,967
52 week range
79.01 - 151.51
Loading...
  • Open147.84
  • Day High147.97
  • Day Low147.84
  • Prev Close148.00
  • 52 Week High151.51
  • 52 Week High Date10/05/21
  • 52 Week Low79.01
  • 52 Week Low Date04/29/22

Key Stats

  • Market Cap10.574B
  • Shares Out71.49M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change7.35

KEY STATS

  • Open147.84
  • Day High147.97
  • Day Low147.84
  • Prev Close148.00
  • 52 Week High151.51
  • 52 Week High Date10/05/21
  • 52 Week Low79.01
  • 52 Week Low Date04/29/22
  • Market Cap10.574B
  • Shares Out71.49M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • YTD % Change7.35

RATIOS/PROFITABILITY

  • EPS (TTM)-14.82
  • P/E (TTM)-9.98
  • Fwd P/E (NTM)-15.64
  • EBITDA (TTM)-616.472M
  • ROE (TTM)-805.56%
  • Revenue (TTM)859.68M
  • Gross Margin (TTM)85.63%
  • Net Margin (TTM)-108.26%
  • Debt To Equity (MRQ)-166.46%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biohaven Pharmaceutical Holding Company Ltd

There is no recent news for this security.

Profile

MORE
Biohaven Pharmaceutical Holding Company Ltd. is a commercial-stage biopharmaceutical company. The Company has a portfolio of therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, including rare disorders. The Company's Neuroinnovation portfolio includes NURTEC ODT (rimegepant) for the acute and preventive treatment of migraine and a pipeline of product candidates across five platforms: calcitonin gene related peptide (CGRP)...
Vlad Coric M.D.
Chairman of the Board, Chief Executive Officer
Matthew Buten
Chief Financial Officer
Address
215 Church St
New Haven, CT
06510-1803
United States

Top Peers

SYMBOLLASTCHG%CHG
SRPT
Sarepta Therapeutics Inc
107.77-1.27-1.16%
NBIX
Neurocrine Biosciences Inc
104.53-2.86-2.66%
NVCR
Novocure Ltd
81.55-2.77-3.29%
MRVI
Maravai LifeSciences Holdings Inc
26.09-0.85-3.16%
KRTX
Karuna Therapeutics Inc
268.10-5.61-2.05%